Changzhou Qianhong BiopharmaLTD Balance Sheet Health
Financial Health criteria checks 6/6
Changzhou Qianhong BiopharmaLTD has a total shareholder equity of CN¥2.4B and total debt of CN¥56.2M, which brings its debt-to-equity ratio to 2.3%. Its total assets and total liabilities are CN¥2.7B and CN¥295.6M respectively. Changzhou Qianhong BiopharmaLTD's EBIT is CN¥158.7M making its interest coverage ratio -10.6. It has cash and short-term investments of CN¥736.8M.
Key information
2.3%
Debt to equity ratio
CN¥56.21m
Debt
| Interest coverage ratio | -10.6x |
| Cash | CN¥736.78m |
| Equity | CN¥2.43b |
| Total liabilities | CN¥295.56m |
| Total assets | CN¥2.73b |
Recent financial health updates
Recent updates
Changzhou Qianhong BiopharmaLTD (SZSE:002550) Has Affirmed Its Dividend Of CN¥0.12
May 26
Changzhou Qianhong Biopharma CO.,LTD (SZSE:002550) Looks Just Right With A 26% Price Jump
May 21Investors Can Find Comfort In Changzhou Qianhong BiopharmaLTD's (SZSE:002550) Earnings Quality
May 02Does Changzhou Qianhong BiopharmaLTD (SZSE:002550) Have A Healthy Balance Sheet?
Mar 24Financial Position Analysis
Short Term Liabilities: 002550's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥208.3M).
Long Term Liabilities: 002550's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥87.3M).
Debt to Equity History and Analysis
Debt Level: 002550 has more cash than its total debt.
Reducing Debt: 002550's debt to equity ratio has reduced from 16.3% to 2.3% over the past 5 years.
Debt Coverage: 002550's debt is well covered by operating cash flow (1303.1%).
Interest Coverage: 002550 earns more interest than it pays, so coverage of interest payments is not a concern.